Generic Active Pharmaceutical Ingredients Market Report

Global and Region Generic Active Pharmaceutical Ingredients Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：164
  • REPORT CODE：GMM988884
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Generic Active Pharmaceutical Ingredients market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Generic Active Pharmaceutical Ingredientsmarket, defines the market attractiveness level of Generic Active Pharmaceutical Ingredients market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Generic Active Pharmaceutical Ingredients industry, describes the types of Generic Active Pharmaceutical Ingredients market, the applications of major players and the market size, and deeply analyzes the current situation of the global Generic Active Pharmaceutical Ingredients market and the development prospects and opportunities of Generic Active Pharmaceutical Ingredients industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Generic Active Pharmaceutical Ingredients market in Chapter 13.

    By Player:

    • AbbVie Inc (US)

    • Eli Lilly and Company (US)

    • Pfizer, Inc (US)

    • Sanofi (France)

    • Bristol-Myers Squibb (US)

    • GlaxoSmithKline plc (UK)

    • Boehringer Ingelheim (Germany)

    • Teva Pharmaceutical Industries Ltd (Israel)

    • Merck & Co, Inc (US)

    • Novartis International AG (Switzerland)

    By Type:

    • Monoclonal Antibodies

    • Hormones

    • Cytokines

    • Fusion Proteins

    • Therapeutic Enzymes

    • Vaccines

    • Blood Factors

    By End-User:

    • Oncology

    • Diabetes

    • Cardiovascular Disease

    • CNS and Neurological Disorders

    • Endocrinology

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Generic Active Pharmaceutical Ingredients Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Generic Active Pharmaceutical Ingredients Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Generic Active Pharmaceutical Ingredients Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Generic Active Pharmaceutical Ingredients Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Generic Active Pharmaceutical Ingredients Market Analysis and Outlook to 2022

    • 7.1 Global Generic Active Pharmaceutical Ingredients Consumption (2017-2022)

    • 7.2 United States Generic Active Pharmaceutical Ingredients Consumption (2017-2022)

    • 7.3 Europe Generic Active Pharmaceutical Ingredients Consumption (2017-2022)

    • 7.4 China Generic Active Pharmaceutical Ingredients Consumption (2017-2022)

    • 7.5 Japan Generic Active Pharmaceutical Ingredients Consumption (2017-2022)

    • 7.6 India Generic Active Pharmaceutical Ingredients Consumption (2017-2022)

    • 7.7 South Korea Generic Active Pharmaceutical Ingredients Consumption (2017-2022)

    8 Region and Country-wise Generic Active Pharmaceutical Ingredients Market Analysis and Outlook to 2028

    • 8.1 Global Generic Active Pharmaceutical Ingredients Consumption Forecast (2022-2028)

    • 8.2 United States Generic Active Pharmaceutical Ingredients Consumption Forecast (2022-2028)

    • 8.3 Europe Generic Active Pharmaceutical Ingredients Consumption Forecast (2022-2028)

    • 8.4 China Generic Active Pharmaceutical Ingredients Consumption Forecast (2022-2028)

    • 8.5 Japan Generic Active Pharmaceutical Ingredients Consumption Forecast (2022-2028)

    • 8.6 India Generic Active Pharmaceutical Ingredients Consumption Forecast (2022-2028)

    • 8.7 South Korea Generic Active Pharmaceutical Ingredients Consumption Forecast (2022-2028)

    9 Global Generic Active Pharmaceutical Ingredients Market Outlook by Types and Applications to 2022

    • 9.1 Global Generic Active Pharmaceutical Ingredients Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hormones Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cytokines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Fusion Proteins Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Therapeutic Enzymes Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Blood Factors Consumption and Growth Rate (2017-2022)

    • 9.2 Global Generic Active Pharmaceutical Ingredients Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global CNS and Neurological Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Endocrinology Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Generic Active Pharmaceutical Ingredients Market Outlook by Types and Applications to 2028

    • 10.1 Global Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Hormones Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Cytokines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Fusion Proteins Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Therapeutic Enzymes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global CNS and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Generic Active Pharmaceutical Ingredients Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Generic Active Pharmaceutical Ingredients Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Generic Active Pharmaceutical Ingredients Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Generic Active Pharmaceutical Ingredients Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Generic Active Pharmaceutical Ingredients Market Competitive Analysis

    • 14.1 AbbVie Inc (US)

      • 14.1.1 AbbVie Inc (US) Company Details

      • 14.1.2 AbbVie Inc (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AbbVie Inc (US) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.2 Eli Lilly and Company (US)

      • 14.2.1 Eli Lilly and Company (US) Company Details

      • 14.2.2 Eli Lilly and Company (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Eli Lilly and Company (US) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.3 Pfizer, Inc (US)

      • 14.3.1 Pfizer, Inc (US) Company Details

      • 14.3.2 Pfizer, Inc (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer, Inc (US) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.4 Sanofi (France)

      • 14.4.1 Sanofi (France) Company Details

      • 14.4.2 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.5 Bristol-Myers Squibb (US)

      • 14.5.1 Bristol-Myers Squibb (US) Company Details

      • 14.5.2 Bristol-Myers Squibb (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bristol-Myers Squibb (US) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.6 GlaxoSmithKline plc (UK)

      • 14.6.1 GlaxoSmithKline plc (UK) Company Details

      • 14.6.2 GlaxoSmithKline plc (UK) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GlaxoSmithKline plc (UK) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.7 Boehringer Ingelheim (Germany)

      • 14.7.1 Boehringer Ingelheim (Germany) Company Details

      • 14.7.2 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.8 Teva Pharmaceutical Industries Ltd (Israel)

      • 14.8.1 Teva Pharmaceutical Industries Ltd (Israel) Company Details

      • 14.8.2 Teva Pharmaceutical Industries Ltd (Israel) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva Pharmaceutical Industries Ltd (Israel) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.9 Merck & Co, Inc (US)

      • 14.9.1 Merck & Co, Inc (US) Company Details

      • 14.9.2 Merck & Co, Inc (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck & Co, Inc (US) Generic Active Pharmaceutical Ingredients Product and Service

    • 14.10 Novartis International AG (Switzerland)

      • 14.10.1 Novartis International AG (Switzerland) Company Details

      • 14.10.2 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Generic Active Pharmaceutical Ingredients

    • Figure Generic Active Pharmaceutical Ingredients Picture

    • Table Global Generic Active Pharmaceutical Ingredients Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Active Pharmaceutical Ingredients Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Active Pharmaceutical Ingredients Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Generic Active Pharmaceutical Ingredients Consumption by Country (2017-2022)

    • Figure United States Generic Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

    • Table Europe Generic Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

    • Figure China Generic Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

    • Figure Japan Generic Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

    • Figure India Generic Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

    • Figure South Korea Generic Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Active Pharmaceutical Ingredients Consumption Forecast by Country (2022-2028)

    • Figure United States Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Generic Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Hormones Consumption and Growth Rate (2017-2022)

    • Figure Global Cytokines Consumption and Growth Rate (2017-2022)

    • Figure Global Fusion Proteins Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Enzymes Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)

    • Figure Global CNS and Neurological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Endocrinology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cytokines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fusion Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Enzymes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CNS and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Generic Active Pharmaceutical Ingredients Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Generic Active Pharmaceutical Ingredients Export by Region (Top 5 Countries) (2017-2028)

    • Table AbbVie Inc (US) (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc (US) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Eli Lilly and Company (US) (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company (US) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Pfizer, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc (US) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Sanofi (France) (Foundation Year, Company Profile and etc.)

    • Table Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi (France) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Bristol-Myers Squibb (US) (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb (US) Generic Active Pharmaceutical Ingredients Product and Service

    • Table GlaxoSmithKline plc (UK) (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc (UK) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (UK) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Boehringer Ingelheim (Germany) (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Israel) (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Merck & Co, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc (US) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc (US) Generic Active Pharmaceutical Ingredients Product and Service

    • Table Novartis International AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US